Czartoryska B, Zimowski J G, Bisko M, Górska D
Department of Genetics, Institute of Psychiatry and Neurology, Warsaw, Poland.
Eur J Hum Genet. 1996;4(5):301-3. doi: 10.1159/000472218.
Arylsulfatase A (ASA) pseudodeficiency (Pd) was defined as the in vitro measurement of low enzyme activity in a healthy person. A variable incidence of the Pd allele was found in different populations; it was 10-20 times higher than that of metachromatic leukodystrophy (MLD). In Poland we estimated the incidence of the Pd allele at 6% and that of isolated 1788 mutation (loss of glycosylation site) at 3%. Out of 8 cases with neurological symptoms and low ASA activity, 2 were found to be homozygous for the Pd allele; 2 MLD patients had healthy siblings homozygous for the Pd allele and another patient's allele bore two mutations, Pd and that causing MLD.
芳基硫酸酯酶A(ASA)假缺陷(Pd)被定义为在健康个体中体外测量到的低酶活性。在不同人群中发现Pd等位基因的发生率存在差异;其比异染性脑白质营养不良(MLD)高10至20倍。在波兰,我们估计Pd等位基因的发生率为6%,孤立的1788突变(糖基化位点缺失)的发生率为3%。在8例有神经症状且ASA活性低的病例中,发现2例为Pd等位基因纯合子;2例MLD患者有健康的同胞为Pd等位基因纯合子,另1例患者的等位基因有两个突变,即Pd和导致MLD的突变。